BCL2 and diffuse large B-cell lymphoma: Therefore, a fully characterized MYC/BCL2 DHL cell line with morphologic features of DLBCL, like RC, will be valuable for researchers in identifying novel targets and pre-clinical screening studies of novel therapies that potentially can benefit patients [28].